247 related articles for article (PubMed ID: 22361502)
1. Secondary gliosarcoma after the treatment of primary glioblastoma multiforme.
Andaloussi-Saghir K; Oukabli M; El Marjany M; Sifat H; Hadadi K; Mansouri H
N Am J Med Sci; 2011 Nov; 3(11):527-30. PubMed ID: 22361502
[TBL] [Abstract][Full Text] [Related]
2. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
[TBL] [Abstract][Full Text] [Related]
3. Spinal metastasis of glioblastoma multiforme before gliosarcomatous transformation: a case report.
Hsu BH; Lee WH; Yang ST; Han CT; Tseng YY
BMC Neurol; 2020 May; 20(1):178. PubMed ID: 32393192
[TBL] [Abstract][Full Text] [Related]
4. [A Patient with Primary Intraventricular Gliosarcoma and Long-term Survival - a Case Report].
Kalita O; Zlevorová M; Megová M; Vaverka M; Trojanec R; Tučková L
Klin Onkol; 2016; 29(6):454-459. PubMed ID: 27951723
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
[TBL] [Abstract][Full Text] [Related]
6. Gliosarcoma. A study of 13 tumors, including p53 and CD34 immunohistochemistry.
Sreenan JJ; Prayson RA
Arch Pathol Lab Med; 1997 Feb; 121(2):129-33. PubMed ID: 9126039
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
[TBL] [Abstract][Full Text] [Related]
8. Giant parieto-occipital lobe pediatric gliosarcoma: Report of a rare entity and review of literature.
Dutta G; Gupta R; Garg M; Singh D; Singh H; Srivastava AK; Jagetia A
Surg Neurol Int; 2018; 9():111. PubMed ID: 29930877
[TBL] [Abstract][Full Text] [Related]
9. Gliosarcoma with multiple extracranial metastases: case report and review of the literature.
Beaumont TL; Kupsky WJ; Barger GR; Sloan AE
J Neurooncol; 2007 May; 83(1):39-46. PubMed ID: 17171442
[TBL] [Abstract][Full Text] [Related]
10. Gliosarcoma: A rare variant of glioblastoma multiforme in paediatric patient: Case report and review of literature.
Meena US; Sharma S; Chopra S; Jain SK
World J Clin Cases; 2016 Sep; 4(9):302-5. PubMed ID: 27672648
[TBL] [Abstract][Full Text] [Related]
11. An autopsy case of primary gliosarcoma with multiple extracranial metastases: pathology after administration of bevacizumab and genetic profile.
Sato Y; Deguchi S; Norose T; Oishi T; Mitsuya K; Sugino T; Akiyama Y; Nagashima T; Urakami K; Shimoda Y; Ohshima K; Hayashi N; Yamaguchi K
Nagoya J Med Sci; 2023 Nov; 85(4):828-835. PubMed ID: 38155632
[TBL] [Abstract][Full Text] [Related]
12. Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma.
Butowski N; Chang SM; Lamborn KR; Polley MY; Pieper R; Costello JF; Vandenberg S; Parvataneni R; Nicole A; Sneed PK; Clarke J; Hsieh E; Costa BM; Reis RM; Hristova-Kazmierski M; Nicol SJ; Thornton DE; Prados MD
Neuro Oncol; 2011 Dec; 13(12):1331-8. PubMed ID: 21896554
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.
Smith DR; Wu CC; Saadatmand HJ; Isaacson SR; Cheng SK; Sisti MB; Bruce JN; Sheth SA; Lassman AB; Iwamoto FM; Wang SH; Canoll P; McKhann GM; Wang TJC
J Neurooncol; 2018 Apr; 137(2):303-311. PubMed ID: 29264835
[TBL] [Abstract][Full Text] [Related]
14. Transformation of IDH-wildtype glioblastoma to gliosarcoma with features of osteosarcoma.
Sobczyk P; Sobstyl M; Acewicz A; Rosa J; Grabiec M; Grajkowska W
Folia Neuropathol; 2024; 62(1):96-101. PubMed ID: 38741436
[TBL] [Abstract][Full Text] [Related]
15. Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy.
Damodaran O; van Heerden J; Nowak AK; Bynevelt M; McDonald K; Marsh J; Lee G
J Clin Neurosci; 2014 Mar; 21(3):478-81. PubMed ID: 24332268
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.
Prados MD; Chang SM; Butowski N; DeBoer R; Parvataneni R; Carliner H; Kabuubi P; Ayers-Ringler J; Rabbitt J; Page M; Fedoroff A; Sneed PK; Berger MS; McDermott MW; Parsa AT; Vandenberg S; James CD; Lamborn KR; Stokoe D; Haas-Kogan DA
J Clin Oncol; 2009 Feb; 27(4):579-84. PubMed ID: 19075262
[TBL] [Abstract][Full Text] [Related]
17. Gliosarcoma in Young Adults: A Rare Variant of Glioblastoma.
Kakkar N; Kaur J; Singh GK; Singh P; Siraj F; Gupta A
World J Oncol; 2017 Apr; 8(2):53-57. PubMed ID: 29147435
[TBL] [Abstract][Full Text] [Related]
18. Giant cell glioblastoma multiforme: report of a case with prolonged survival and transformation to gliosarcoma.
Deb P; Sharma MC; Chander B; Mahapatra AK; Sarkar C
Childs Nerv Syst; 2006 Mar; 22(3):314-9. PubMed ID: 16133270
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of temozolomide treatment in patients with high-grade glioma.
Oshiro S; Tsugu H; Komatsu F; Ohmura T; Ohta M; Sakamoto S; Fukushima T; Inoue T
Anticancer Res; 2009 Mar; 29(3):911-7. PubMed ID: 19414327
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients.
Han SJ; Yang I; Ahn BJ; Otero JJ; Tihan T; McDermott MW; Berger MS; Prados MD; Parsa AT
Cancer; 2010 Mar; 116(5):1358-66. PubMed ID: 20052717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]